Eliem Therapeutics Inc (ELYM)

Finanzdaten der Eliem Therapeutics Inc-Aktie (ELYM)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	41.33% 3.005	5.122	5.001	6.714	23.44
Operating Income/Loss	41.33% -3.005	-5.122	-5.001	-6.714	-23.44
Income/Loss From Continuing Operations Before Tax	53.39% -1.697	-3.641	-3.968	-5.22	-22.29
Income/Loss From Continuing Operations After Tax	53.39% -1.697	-3.641	-3.968	-5.22	-22.29
Net Income/Loss	53.39% -1.697	-3.641	-3.968	-5.22	-22.29
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	14,949% 27.64	0.1837	27.07	26.84	26.49
Diluted Average Shares	14,949% 27.64	0.1837	27.07	26.84	26.49
Basic Earnings Per Share	53.85% -0.06	-0.13	-0.15	-0.19	-0.84
Diluted Earnings Per Share	53.85% -0.06	-0.13	-0.15	-0.19	-0.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-